Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin

Clinica Chimica Acta

Volumn 382, Issue 1-2, 2007, Pages 59-64

  Kisugi, Reiko ^a   Kouzuma, Takuji ^b   Yamamoto, Tamotsu ^b   Akizuki, Setsuko ^a   Miyamoto, Hiroyasu ^a   Someya, Yasutoshi ^a   Yokoyama, Junichi ^a   Abe, Ikurho ^a   Hirai, Noriyuki ^a   Ohnishi, Akihiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Asahi Kasei Pharma Corporation   (Japan)

Author keywords

Diabetes mellitus; Fluorescence; Glycated albumin; Glycation; LC MS

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLUTAMIC ACID; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; PROTEINASE; TRYPTOPHAN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FLUOROMETRY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION;

BLOOD GLUCOSE; CHROMATOGRAPHY, LIQUID; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FLUOROMETRY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; SERUM ALBUMIN;

EID: 34249084962     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.04.001     Document Type: Article

References (18)

1. Day J.F., Thorpe S.R., and Baynes J.W. Nonenzymatically glucosylated albumin. J Biol Chem 254 (1979) 595-597
2. Lee A.T., and Cerami A. Role of glycation in aging. Ann N Y Acad Sci 663 (1992) 63-70
3. Rodriguez-Segade S., Rodriguez J., Mayan D., and Camina F. Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine. Diabetes Care 28 (2005) 437-439
4. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18 (1995) 440-447
5. Koizumi K., Ikeda C., Ito M., et al. Influence of glycosylation on the drug binding of human serum albumin. Biomed Chromatogr 12 (1988) 203-210
6. Bourdon E., Loreau N., and Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 13 (1999) 233-244
7. Nakajou K., Watanabe H., Kragh-Hansen U., Maruyama T., and Otagiri M. The effect of glycation on the stricture, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim Biophys Acta 1623 (2003) 88-97
8. Iberg N., and Flückiger R. Nonenzymatic glycosylation of albumin in vivo. J Biol Chem 261 (1986) 13542-13545
9. Garlick R.L., and Mazer J.S. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 258 (1983) 6142-6146
10. Kouzuma T., Uematsu Y., Usami T., and Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta 346 (2004) 135-143
11. Matsuda N., and Takahashi H. Standards for the quantitative analysis of human serum albumin. Rinsho Byori 23 (1975) 889-894 (in Japanese)
12. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., and Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 324 (2002) 61-71
13. Jiskoot W., Hlady V., Naleway J.J., and Herron J.N. Application of fluorescence spectroscopy for determining the structure and function of proteins. Pharm Biotechnol 7 (1995) 1-63
14. Zoellner H., Hou J.Y., Poljak A., et al. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylation albumin. Biochem Biophys Res Commun 284 (2001) 83-89
15. Gugliucci A., and Menini T. Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains. Life Sci 62 (1998) 2141-2150
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
17. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
18. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese's patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117